mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.057 |
0.7 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.069 |
0.7 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
0.053 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |